Mirati Therapeutics, Inc. announced initial preclinical results evaluating its investigational synthetic lethal PRMT5 inhibitor in…
Clinical trial results of RET kinase inhibitor selpercatinib show that the targeted therapy was effective…
Racial differences in genetic mutations were observed among early-onset colorectal cancers (CRC), according to data…
Patients with non-small cell lung cancer (NSCLC) whose cancer cells have low levels of aneuploidy…
Treatment with the neoantigen cancer vaccine PGV-001 following standard-of-care adjuvant therapy was well tolerated and…
Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumour tissue identified the…
Men who had a high genetic risk of developing prostate cancer were less likely to…
Tumour mutational burden (TMB) was an accurate predictor of response to treatment with immune checkpoint…
A liquid biopsy test to assess plasma cell-free DNA (cfDNA) integrity could improve the accuracy…
Women diagnosed with ovarian cancer were more than three times more likely than the general…